Already, GLP-1 weight loss prescriptions Wegovy, Rybelsus and Saxendaalong with Ozempicare the single biggest driver of employer health costs, adding 1% to the total premium expense for 2025, data released last fall from the benefits consultancy Aon said
These are not abstract risks
1 , 2 The prevalence of melasma exhibits striking variability across populations and ethnicities, with reported overall prevalence rates ranging from of 1% in the general population to as high as 950% in high-risk populations, particularly dark-skinned women (Fitzpatrick phototypes IIIIV) in their third and fourth decades of life
Realistic Results: A Month By Month Outlook Setting the right expectations keeps you from quitting during the slow stretches and from panicking during the fast ones
Lipid Panels: Cholesterol (HDL, LDL), triglycerides